An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells

Journal of Cell Science

Volumn 121, Issue 15, 2008, Pages 2578-2587

  Wang, Hongbo ^a   Sun, Daqian ^a   Ji, Peng ^a   Mohler, James ^b   Zhu, Liang ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Androgen receptor; Androgen dependent proliferation; D box dependent degradation; Prostate cancer cells; Skp2

Indexed keywords

ANDROGEN RECEPTOR; DNA; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FLANKING REGION; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANDROGENS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE SILENCING; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION;

EID: 50249098664     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.030742     Document Type: Article

References (61)

1. Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A. and Sawyers, C. L. (1999). Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol. Cell. Biol. 19, 5143-5154.
2. Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. and Pagano, M. (2004). Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428, 190-193.
3. Ben-Izhak, O., Lahav-Baratz, S., Meretyk, S., Ben-Eliezer, S., Sabo, E., Dirnfeld, M., Cohen, S. and Ciechanover, A. (2003). Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kipl in prostate cancer. J. Urol. 170, 241-245.
4. Bernard, D., Pourtier-Manzanedo, A., Gil, J. and Beach, D. H. (2003). Myc confers androgen-independent prostate cancer cell growth. J. Clin. Invest. 112, 1724-1731.
5. Cardozo, T. and Pagano, M. (2004). The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol. 5, 739-751.
6. Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G. and Sawyers, C. L. (2004). Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33-39.
7. Craft, N., Shostak, Y., Carey, M. and Sawyers, C. L. (1999). A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. 5, 280-285.
8. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C, Trapman, J., Hittmair, A., Bartsch, G. and Klocker, H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478.
9. Cunha, G. R., Ricke, W., Thomson, A., Marker, P. C., Risbridger, G., Hayward, S. W., Wang, Y. Z., Donjacour, A. A. and Kurita, T. (2004). Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J. Steroid Biochem. Mol. Biol. 92, 221-236.
10. DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., Fero, M., Tibshirani, R., Brown, P. O. and Brooks, J. D. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 3, research0032.1-research0032.12.
11. Donjacour, A. A. and Cunha, G. R. (1993). Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 132, 2342-2350.
12. Drobnjak, M., Melamed, J., Taneja, S., Melzer, K., Wieczorek, R., Levinson, B., Zeleniuch-Jacquotte, A., Polsky, D., Ferrara, J., Perez-Soler, R. et al. (2003). Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin. Cancer Res. 9, 2613-2619.
13. Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C. and Naldini, L. (2002). Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13, 243-260.
14. Gao, J., Arnold, J. T. and Isaacs, J. T. (2001). Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res. 61, 5038-5044.
15. Geck, P., Szelei, J., Jimenez, J., Lin, T. M., Sonnenschein, C. and Soto, A. M. (1997). Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 63, 211-218.
16. Glotzer, M., Murray, A. W. and Kirshner, M. W. (1991). Cychn is degraded by the ubiquity pathway. Nature 349, 132-138.
17. Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S. and Wilson, E. M. (2001). A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 61, 4315-4319.
18. Haag, P., Bektic, J., Bartsch, G., Klocker, H. and Eder, I. E. (2005). Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J. Steroid Biochem. Mol. Biol. 96, 251-258.
19. Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
20. Hara, T., Miyazaki, J., Araki, H., Yamaoka, M., Kanzaki, N., Kusaka, M. and Miyamoto, M. (2003). Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. Cancer Res. 63, 149-153.
21. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A. and Murphy, G. P. (1983). LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809-1818.
22. Isaacs, J. T. and Isaacs, W. B. (2004). Androgen receptor outwits prostate cancer drugs. Nat. Med. 10, 26-27.
23. Ji, P., Jiang, H., Rekhtman, K., Bloom, J., Ichetovkin, M., Pagano, M. and Zhu, L. (2004). An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell 16, 47-58.
24. Ji, P., Goldin, L., Ren, H., Sun, D., Guardavaccaro, D., Pagano, M. and Zhu, L. (2006). Skp2 contains a novel cyclin a binding domain that directly protects cyclin a from inhibition by p27Kip1. J. Biol. Chem. 281, 24058-24069.
25. Kim, D., Gregory, C. W., French, F. S., Smith, G. J. and Mohler, J. L. (2002). Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am. J. Pathol. 160, 219-226.
26. Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N. et al. (1997). Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med. 3, 402-408.
27. Li, T. H., Zhao, H., Peng, Y., Beliakoff, J., Brooks, J. D. and Sun, Z. (2007). A promoting role of androgen receptor in androgen-sensifive and -insensitive prostate cancer cells. Nucleic Acids Res. 35, 2767-2776.
28. Ling, M. T., Chan, K. W. and Choo, C. K. (2001). Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. J. Endocrinol. 170, 287-296.
29. Lu, L., Schulz, H. and Wolf, D. A. (2002). The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol. 3, 22.
30. Lu, S., Liu, M., Epner, D. E., Dai, S. Y. and Tsai, M. J. (1999). Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol. 13, 376-384.
31. Marker, P. C., Donjacour, A. A., Dahiya, R. and Cunha, G. R. (2003). Hormonal, cellular, and molecular control of prostatic development. Dev. Biol. 253, 165-174.
32. Massie, C. E., Adryan, B., Barbosa-Morais, N. L., Lynch, A. G., Tran, M. G., Neal, D. E. and Mills, I. G. (2007). New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep. 8, 871-878.
33. Migliaccio, A., Di Domenico, M., Castoria, G., Nanayakkara, M., Lombardi, M., de Falco, A., Bilancio, A., Varricchio, L., Ciociola, A. and Auricchio, F. (2005). Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 65, 10585-10593.
34. Nakayama, K. I. and Nakayama, K. (2005). Regulation of the rcell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16, 323-333.
35. Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., Hood, L. and Lin, B. (2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. USA 99, 11890-11895.
36. Pretlow, T. G., Wolman, S. R., Micale, M. A., Pelley, R. J., Kursh, E. D., Resnick, M. I., Bodner, D. R., Jacobberger, J. W., Delmoro, C. M., Giaconia, J. M. et al. (1993). Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst. 85, 394-398.
37. Rodier, G., Makris, C., Coulombe, P., Scime, A., Nakayama, K., Nakayama, K. I. and Meloche, S. (2005). p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J. Cell Biol. 168, 55-66.
38. Segawa, T., Nau, M. E., Xu, L. L., Chilukuri, R. N., Makarem, M., Zhang, W., Petrovics, G., Sesterhenn, I. A., McLeod, D. G., Moul, J. W. et al. (2002). Androgen-induced expression of endoplasmic reticulurn (ER) stress response genes in prostate cancer cells. Oncogene 21, 8749-8758.
39. Shim, E. H., Johnson, L., Noh, H. L., Kim, Y. J., Sun, H., Zeiss, C. and Zhang, H. (2003). Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Cancer Res. 63, 1583-1588.
40. Sramkoski, R. M., Pretlow, T. G., 2nd, Giaconia, J. M., Pretlow, T. P., Schwartz, S., Sy, M. S., Marengo, S. R., Rhim, J. S., Zhang, D. and Jacobberger, J. W. (1999). A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev. Biol. Anim. 35, 403-409.
41. Sun, D., Melegari, M., Sridhar, S., Rogler, C. E. and Zhu, L. (2006). A multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. BioTechniques 41, 59-63.
42. Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B. et al. (2007). Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595-599.
43. Tsihlias, J., Zhang, W., Bhattacharya, N., Flanagan, M., Klotz, L. and Slingerland, J. (2000). Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Oncogene 19, 670-679.
44. Velasco, A. M., Gillis, K. A., Li, Y., Brown, E. L., Sadler, T. M., Achilleos, M., Greenberger, L. M., Frost, P., Bai, W. and Zhang, Y. (2004). Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145, 3913-3924.
45. Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G., Jenster, G. J. T., Brinkmann, A. O. and Mulder, E. (1992). The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J. Steroid Biochem. Mol. Biol. 41, 665-669.
46. Waghray, A., Feroze, F., Schober, M. S., Yao, F., Wood, C., Puravs, E., Krause, M., Hanash, S. and Chen, Y. Q. (2001). Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1, 1327-1338.
47. Waltregny, D., Leav, I., Signoretti, S., Soung, P., Lin, D., Merk, F., Adams, J. Y., Bhattacharya, N., Cirenei, N. and Loda, M. (2001). Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Mol. Endocrinol. 15, 765-782.
48. Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Janne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J. and Brown, M. (2007). A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27, 380-392.
49. Wei, W., Ayad, N. G., Wan, Y., Zhang, G. J., Kirschner, M. W. and Kaelin, W. G., Jr (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198.
50. Whitacre, D. C., Chauhan, S., Davis, T., Gordon, D., Cress, A. E. and Miesfeld, R. L. (2002). Androgen induction of in vitro prostate cell differentiation. Cell Growth Differ. 13, 1-11.
51. Wirbelauer, C., Sutterluty, H., Blondel, M., Gstaiger, M., Peter, M., Reymond, F. and Krek, W. (2000). The F-box protein Skp2 is a ubiquitylation target of a Cull-based core ubiquitin ligase complex: evidence for a role of Cull in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J. 19, 5362-5375.
52. Wright, M. E., Tsai, M. J. and Aebersold, R. (2003). Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Mo.l Endocrinol. 17, 1726-1737.
53. Wu, H. C., Hsieh, J. T., Gleave, M. E., Brown, N. M., Pathak, S. and Chung, L. W. (1994). Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer 57, 406-412.
54. Xu, L. L., Su, Y. P., Labiche, R., Segawa, T., Shanmugam, N., McLeod, D. G., Moul, J. W. and Srivastava, S. (2001). Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int. J. Cancer 92, 322-328.
55. Yang, G., Ayala, G., De Marzo, A., Tian, W., Frolov, A., Wheeler, T. M., Thompson, T. C. and Harper, J. W. (2002). Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin. Cancer Res. 8, 3419-3426.
56. Yeh, S., Lin, H. K., Kang, H. Y., Thin, T. H., Ling M. F. and Chang, C. (1999). From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA 96, 5458-5463.
57. Yung, Y., Walker, J. L., Roberts, J. M. and Assoian, R. K. (2007). A Skp2 autoinduction loop and restriction point control. J. Cell Biol. 178, 741-747.
58. Zegarra-Moro, O. L., Schmidt, L. J., Huang, H. and Tindall, D. J. (2002). Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res. 62, 1008-1013.
59. Zhang, H., Kobayashi, R., Galaktionov, K. and Beach, D. (1995). p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915-925.
60. Zhang, L. and Wang, C. (2005). F-box protein Skp2: a novel transcriptional target of E2F. Oncogene 25, 2615-2627.
61. Zhu, L. and Skoultchi, A. I. (2001). Coordinating cell proliferation and differentiation. Curr. Opin. Genet. Dev. 11, 91-97.